[Clinical assays of norgestrel associated with ethinyl estradiol].
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D001831:Body Temperature; D002582:Cervix Mucus / Q000032:analysis; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology; D004361:Drug Tolerance; D004412:Dysmenorrhea / Q000188:drug therapy; D004715:Endometriosis / Q000188:drug therapy; D004717:Endometrium / Q000473:pathology; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy; D008111:Liver Function Tests; D008595:Menorrhagia / Q000188:drug therapy; D008599:Menstruation Disturbances / Q000139:chemically induced; D008796:Metrorrhagia / Q000188:drug therapy; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011276:Pregnanediol / Q000652:urine; D011293:Premenstrual Syndrome / Q000188:drug therapy; D011372:Progestins / Q000008:administration & dosage*
D003276:Contraceptives, Oral; D011372:Progestins; D004997:Ethinyl Estradiol; D011276:Pregnanediol
Essais cliniques du norgestrel associé à l'éthinyl-oestradiol.